Table 2 |
||||||||
|
Patient characteristics. |
||||||||
|
Pt |
Agea |
Sex |
Diagnosis |
Localization |
Histologyb |
MYCNc |
Treatment and follow-up |
Status |
|
|
||||||||
|
1. |
3 mnts |
F |
NB IV S |
Adnex and liver metastasis |
UD |
No |
05/'01 surgery + chemo |
Alive |
|
2. |
3 yrs |
M |
NB IV |
Supraclavicular and BM metastases |
PD |
No |
02/'03 surgery + chemo 07/'03 chemo, SCR + RT |
Alive |
|
3. |
4 mnts |
M |
NB II |
Pos. lymphnodes with unknown primary tumor |
PD |
No |
01/'03 surgery + chemo |
Alive |
|
4. |
5 mnts |
M |
NB IV S |
Spine and bone/liver metastases |
PD |
No |
01/'01 surgery + chemo |
Alive |
|
5. |
14 mnts |
F |
NB II |
Spine |
PD |
No |
02/'04 surgery + chemo |
Alive |
|
6. |
4 mnts |
F |
NB II |
Adnex |
PD |
No |
07/'01 surgery + chemo |
Alive |
|
7. |
2 yrs |
F |
NB III |
Adnex |
D |
No |
01/'02 chemo + sugery |
Alive |
|
8. |
3 mnts |
M |
NB I |
Adnex |
D |
No |
02/'02 Surgery |
Alive |
|
9. |
2 yrs |
M |
NB IV |
Adnex with bone/BM metastases |
Dd |
No |
12/'03 chemo, SCR + RT 10/'04 relapse treatment |
d.o.d. |
|
10. |
8 mnts |
F |
NB III |
Spine |
PD |
No |
04/'02 surgery + chemo 12/'02 Surgery spinal relapse |
Alive |
|
11. |
18 mnts |
F |
NB III |
Adnex |
UDd |
20× |
09/'98 MIBG, chemo + surgery 04/'99 chemo and SCR |
d.o.d. |
|
12. |
2 yrs |
M |
NB IV |
Adnex and bone metastases |
PDd |
37 × |
07/'98 surgery, chemo + SCR |
d.o.d. |
|
13. |
6 yrs |
M |
NB III |
Adnex |
UD |
27 × |
01/'00 surgery, chemo + SCR 11/'03 surgery, chemo + RT |
d.o.d. |
|
14. |
19 mnts |
M |
NB IV |
Adnex and spine metastasis |
UD |
49 × |
03/'98 MIBG, chemo + surgery |
d.o.d. |
|
15. |
18 mnts |
M |
NB IV |
Adnex and multiple distal metastases |
n.d. |
139 × |
06/'99 chemo + RT |
d.o.d. |
|
16. |
16 mnts |
M |
NB IV |
Adnex and multiple distal metastases |
UD |
74 × |
01/'97 chemo + surgery |
d.o.d. |
|
|
||||||||
|
aAge at diagnosis bNeuroblastoma differentiation as assessed by pathologist. D = differentiated; PD = poorly differentiated; UD = undifferentiated cMYCN genomic amplification, as determined with qPCR dPatient has been treated before surgery BM = bone marrow; d.o.d. = death of disease; MIBG = meta-iodobenzylguanidine; SCR = stem cell rescue; RT = radiotherapy. |
||||||||
|
Jacobs et al. BMC Cancer 2009 9:239 doi:10.1186/1471-2407-9-239 |
||||||||